Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism - PubMed (original) (raw)
N V Morgan, M Savino, J P de Winter, C G van Berkel, M E Hoatlin, L Ianzano, R A Gibson, F Arwert, A Savoia, C G Mathew, J C Pronk, H Joenje
Affiliations
- PMID: 10431244
- DOI: 10.1038/11956
Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism
Q Waisfisz et al. Nat Genet. 1999 Aug.
Abstract
Somatic mosaicism due to reversion of a pathogenic allele to wild type has been described in several autosomal recessive disorders. The best known mechanism involves intragenic mitotic recombination or gene conversion in compound heterozygous patients, whereby one allele serves to restore the wild-type sequence in the other. Here we document for the first time functional correction of a pathogenic microdeletion, microinsertion and missense mutation in homozygous Fanconi anaemia (FA) patients resulting from compensatory secondary sequence alterations in cis. The frameshift mutation 1615delG in FANCA was compensated by two additional single base-pair deletions (1637delA and 1641delT); another FANCA frameshift mutation, 3559insG, was compensated by 3580insCGCTG; and a missense mutation in FANCC(1749T-->G, Leu496Arg) was altered by 1748C-->T, creating a cysteine codon. Although in all three cases the predicted proteins were different from wild type, their cDNAs complemented the characteristic hypersensitivity of FA cells to crosslinking agents, thus establishing a functional correction to wild type.
Similar articles
- The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F, Scheper RJ, Kruyt FA, Hoatlin ME, Joenje H. de Winter JP, et al. Hum Mol Genet. 2000 Nov 1;9(18):2665-74. doi: 10.1093/hmg/9.18.2665. Hum Mol Genet. 2000. PMID: 11063725 - Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D, Oda T, Yagasaki H, Nakasato K, Taniguchi T, D'Andrea AD, Asano S, Yamashita T. Adachi D, et al. Hum Mol Genet. 2002 Dec 1;11(25):3125-34. doi: 10.1093/hmg/11.25.3125. Hum Mol Genet. 2002. PMID: 12444097 - A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G, Naf D, Garcia-Higuera I, Wasik J, Cheng A, Yamashita T, Tipping A, Morgan N, Mathew CG, D'Andrea AD. Kupfer G, et al. Exp Hematol. 1999 Apr;27(4):587-93. doi: 10.1016/s0301-472x(99)00022-3. Exp Hematol. 1999. PMID: 10210316 - Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
Yamashita T, Nakahata T. Yamashita T, et al. Int J Hematol. 2001 Jul;74(1):33-41. doi: 10.1007/BF02982547. Int J Hematol. 2001. PMID: 11530803 Review. - [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
Li ZY, Zou YF, Deng YB. Li ZY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):231-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15157341 Review. Chinese.
Cited by
- Hemophagocytic Lymphohistiocytosis Gene Variants in Severe Aplastic Anemia and Their Impact on Hematopoietic Cell Transplantation Outcomes.
Rafati M, McReynolds LJ, Wang Y, Hicks B, Jones K, Spellman SR, He M, Bolon YT, Arrieta-Bolaños E, Saultz JN, Lee SJ, Savage SA, Gadalla SM. Rafati M, et al. Transplant Cell Ther. 2024 Aug;30(8):770.e1-770.e10. doi: 10.1016/j.jtct.2024.05.017. Epub 2024 May 27. Transplant Cell Ther. 2024. PMID: 38810947 - A self-repair history: compensatory effect of a de novo variant on the FANCA c.2778+83C>G splicing mutation.
Persico I, Fontana G, Faleschini M, Zanchetta ME, Ammeti D, Cappelli E, Corsolini F, Mosa C, Guarina A, Bogliolo M, Surrallés J, Dufour C, Farruggia P, Savoia A, Bottega R. Persico I, et al. Front Genet. 2023 Jul 20;14:1209138. doi: 10.3389/fgene.2023.1209138. eCollection 2023. Front Genet. 2023. PMID: 37547463 Free PMC article. - Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes.
van den Akker PC, Bolling MC, Pasmooij AMG. van den Akker PC, et al. Biomedicines. 2022 Aug 29;10(9):2118. doi: 10.3390/biomedicines10092118. Biomedicines. 2022. PMID: 36140224 Free PMC article. Review. - Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.
Avagyan S, Shimamura A. Avagyan S, et al. Front Oncol. 2022 Mar 9;12:813149. doi: 10.3389/fonc.2022.813149. eCollection 2022. Front Oncol. 2022. PMID: 35356204 Free PMC article. Review. - Translational research for bone marrow failure patients.
Malouf C, Loughran SJ, Wilkinson AC, Shimamura A, Río P. Malouf C, et al. Exp Hematol. 2022 Jan;105:18-21. doi: 10.1016/j.exphem.2021.11.004. Epub 2021 Nov 18. Exp Hematol. 2022. PMID: 34801643 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous